Loading…
Held by equity mutual funds in 33 disclosed months, Jan 2024 to Sep 2026.
Glenmark Life Sciences Limited (Pharmaceuticals & Biotechnology) was held by 10 active equity mutual funds in September 2026, ₹888 Cr in all (up 0 funds from Aug 2026). The largest position was quant Healthcare Fund at 6.2% of its portfolio. During the month 1 fund entered and 1 exited. Funds have disclosed holding it since Jan 2024.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
How many equity funds held the company each month, and the value they held.